Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]
News [6431]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in...
Dr Johannes Ettl - Technical University, Munich, Germany
EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients with advanced breast cancer ( Dr Johannes Ettl - Technical University, Munich, Germany )
12 Jun 2019
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland...
Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers: Results from a phase II basket trial ( Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA )
11 Jun 2019
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2...
Dr Adrienne Waks - Dana-Farber Cancer Institute, Boston, USA
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2 mutated metastatic breast cancer ( Dr Adrienne Waks - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
Updates in metastatic and early-stage breast cancer
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Updates in metastatic and early-stage breast cancer ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
ADAPTCycle: Adjuvant personalised therapy comparing endocrine therapy plus...
Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany
ADAPTCycle: Adjuvant personalised therapy comparing endocrine therapy plus ribociclib versus chemotherapy in early breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )
11 Jun 2019
SWOG 1314: A study of co-expression extrapolation (COXEN) with neoadjuvant...
Prof Thomas Flaig - University of Colorado Denver, Denver, USA
SWOG 1314: A study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for muscle-invasive bladder cancer ( Prof Thomas Flaig - University of Colorado Denver, Denver, USA )
10 Jun 2019
Genetic testing and PARP inhibitors in metastatic prostate cancer
Dr Neal Shore and Dr Joaquin Mateo
Genetic testing and PARP inhibitors in metastatic prostate cancer ( Dr Neal Shore and Dr Joaquin Mateo )
7 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer highlights from ASCO 2019 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
6 Jun 2019
Carfilzomib and irinotecan in relapsed small cell lung cancer
Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA
Carfilzomib and irinotecan in relapsed small cell lung cancer ( Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA )
6 Jun 2019
Predictive models for treatment risk in cancer
Dr Charlotte Moser - Founder weCancerTALK
Predictive models for treatment risk in cancer ( Dr Charlotte Moser - Founder weCancerTALK )
5 Jun 2019
The Global Health Catalyst initiative
Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts
The Global Health Catalyst initiative ( Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts )
5 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation